C-RAD proudly announces their research partnership with PSG Hospitals, Coimbatore,
The PSG Hospitals in
Dr.
“We are particularly proud of the partnership with PSG and their modern mindset to SGRT. They feel as strongly as we do that SGRT is the future, and that we need to collaborate broadly to ensure we create awareness across
The collaborationis set to start in 2023 and will include several research papers on SGRT from an Indian perspective using the C-RAD Catalyst HD+ system at
“Training & Education as well as research are two important pillars of our strategy for the Indian market. Our strategy has proven to be successful, and I am confident that we can capitalize on our position moving forward. To establish our technology in the market, it is important to team up with leading educational hospitals, such as PSG.” says
About C-RAD
C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient’s motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.
C-RAD. Inspiring excellence in cancer treatment.
For more information on C-RAD, please visit http://www.c-rad.com
For further information:
© Modular Finance, source